Mon, May 23, 2022

Hepatitis and Liver Diseases

 | Post date: 2019/03/3 | 
Hepatitis and Liver Diseases



 
 
 
1- Alavian SM, Hajarizadeh B, Lankarani KB, Sharafi H, Daryani NE, Merat S, Mohraz M, Mardani M, Fattahi MR, Poustchi H, Nikbin M. Recommendations for the clinical management of hepatitis C in Iran: a consensus-based national guideline. Hepatitis monthly. 2016 Aug;16(8).
2- Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next steps toward eradication of hepatitis C in the era of direct acting antivirals. Hepatitis monthly. 2016 Apr;16(4).

 
Abstract

Hepatitis and liver diseases are global health concerns. There are a set of complications with liver inflammation which could result in cirrhosis and liver failure. Fortunately, with recent advances of hepatology in terms of prevention, management and treatment, laboratory diagnosis and monitoring of liver diseases have transformed greatly. Some of these achievements are advances in diagnosis of viral hepatitis and non-invasive diagnosis of liver fibrosis based on laboratory seromarkers. With knowledge of increasing burden of liver diseases, the role of laboratories in diagnosis and management of liver diseases will greatly be expanded in near future.








 

























 
Prof. Seyyed Moayyed Alavian

Prof. Alavian graduated in medicine from Tehran University of Medical Sciences. He had the second rank in the board certification test. He established the first hepatitis clinic and was founder and editor-in-chief of Hepatitis Monthly Journal. He has been a member of the National Committee for Hepatitis in the Iranian Ministry of Health and Medical Education. He has been the professor and chairman of Digestive and Liver Research Center at Baqiyatallah hospital.
Main activities: Health policies in epidemiological fields for hepatitis viruses and methods for integrating new protocols for controlling these infections, the responsibility of directing the control of hepatitis C in specific patients in the country over the past five years, the founder and the chairman of  Iran Hepatitis Network.

                                                                                                       Email: Alavianthc.ir

 

View: 662 Time(s)   |   Print: 312 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)